
Eris Lifesciences Limited has informed the Exchange regarding a press release dated August 26, 2025, titled "Eris Lifesciences Receives ANVISA approval for Sterile Injectable Facility".
Filed with NSE ·

Eris Lifesciences Limited has informed the Exchange regarding a press release dated August 26, 2025, titled "Eris Lifesciences Receives ANVISA approval for Sterile Injectable Facility".
6ix hasn’t read this filing yet.
Follow Eris Lifesciences into a list and get an email when it puts out news.
Follow Eris Lifesciences